Skip to main content
Elman Retina Group
Elman Retina Group
The most compassionate care in sight
Patient PortalPay BillRefer a Patient
410-686-3000Book Appointment
  • Home
  • About
    • About Us
    • Awards & Research
    • Clinical Trials
    • News & Updates
    • Patient Stories
    • Our Team
  • Our Services
  • Locations
  • Doctors
  • Patients
  • Blog
  • Contact

Elman Retina Group

  • 410-686-3000
  • 9114 Philadelphia Road, Suite 310
  • Rosedale, MD 21237

Patient Resources

  • Patient Portal
  • Pay Your Bill
  • Physician Referral Form
  • Patient Information
  • Online Forms
  • Accepted Insurance
  • HIPAA Notice
  • Leave a Review

Conditions & Services

  • Macular Degeneration
  • Diabetic Retinopathy
  • Retinal Detachment
  • Macular Edema
  • All Services →
  • All Conditions →

Quick Links

  • About Us
  • Our Doctors
  • Office Locations
  • For Referring Doctors
  • Blog & News
  • Contact Us

© 2026 Elman Retina Group. All rights reserved.

Privacy Policy·HIPAA Notice

The Most Compassionate Care In Sight — Serving Baltimore, Pikesville, Glen Burnie, Catonsville, and Rosedale.

We value your privacy. We use optional cookies for bot prevention (reCAPTCHA) to protect our forms. Essential site functionality works without them.
Home / Blog / Article
Research5 min read

Surgical Management of Uveitis: Dr. Dao Co-Authors Comprehensive Clinical Review

David Dao, M.D.•March 27, 2026

Navigating the Complexities of Uveitis Surgery

Uveitis, a group of intraocular inflammatory disorders, can lead to severe and sight-threatening complications. While medical therapy usually serves as the first-line treatment, surgical intervention may become necessary for both diagnostic and therapeutic purposes. Because of the underlying inflammation, vitreoretinal surgery in these patients presents unique challenges.

Dr. David Dao recently co-authored a comprehensive review article, indexed by the National Institutes of Health (NIH) and published in Advances in Ophthalmology and Optometry (2026), titled "Vitreoretinal Surgery in Uveitis: Indications, Techniques, and Outcomes." The publication provides a guide for ophthalmologists to safely manage uveitis patients before, during, and after surgical procedures.

When Is Surgery Necessary?

The study outlines two primary indications for surgical intervention in patients with uveitis:

1. Diagnostic Vitrectomy

When the cause of severe inflammation remains unknown despite extensive clinical testing, or when there is concern for infectious etiologies or malignancies like vitreoretinal lymphoma, a diagnostic vitrectomy is crucial. Sampling the vitreous, subretinal fluid, or performing a chorioretinal biopsy can secure a definitive diagnosis and guide targeted therapeutic plans.

2. Therapeutic Interventions

Surgery is also employed to repair severe complications stemming from uveitis, including:

  • Refractory Uveitis & Macular Edema: Removing the inflammatory mediators within the vitreous gel can often improve vision and lower the need for ongoing systemic therapy in patients who do not respond adequately to medical management.
  • Acute Retinal Necrosis (ARN): This devastating infectious condition carries an extremely high risk of rhegmatogenous retinal detachment. Complex surgical repair, often requiring long-term silicone oil tamponade, is regularly needed to preserve anatomical integrity safely.
  • Epiretinal Membranes & Macular Holes: Chronic inflammation can cause persistent scar tissue on the macula. Surgical peeling of these membranes can significantly improve anatomic structure and visual outcomes.

Precision and Perioperative Care

As Dr. Dao and his colleagues highlight, carefully managing perioperative inflammation is critical. Performing surgery in an inflamed eye can exacerbate post-surgical complications. The review recommends ensuring disease quiescence for at least three months prior to elective procedures when possible, typically supplemented with a brief course of perioperative systemic or local corticosteroids to prevent dangerous reactivation of inflammation.

Advancing Patient Care

At the Elman Retina Group, we employ the latest surgical techniques and adhere to rigorous, evidence-based perioperative protocols to ensure the best possible outcomes for our patients with uveitis. By contributing to vital scientific publications like this one, our physicians continue to support and advance the standard of care in the broader medical community.

If you are managing uveitis and want to learn more about comprehensive medical or surgical treatment options, please contact our office at 410-686-3000 to schedule a consultation with Dr. Dao.

#uveitis#vitreoretinal surgery#clinical research#macular edema#retinal detachment
Share this article:𝕏 PostFacebookLinkedIn✉ Email

Related Articles

Elman Retina Group Presents Landmark Research at ARVO 2026
Research

Elman Retina Group Presents Landmark Research at ARVO 2026

Moshe Horowitz and Dr. Michael J. Elman presented landmark research at the 2026 ARVO Annual Meeting in Denver, exploring the association between post-injection corneal abrasions and dry eye disease.

May 6, 20263 min read
Research

The Link Between Digestive Health and Vision: Dr. Schechet's New Research

A recent multicenter study co-authored by Dr. Schechet published in Frontiers in Ophthalmology explores how gastrointestinal and liver conditions can lead to vision-threatening vitamin A deficiency.

Apr 29, 20264 min read
How a Landmark Study Changed Diabetic Eye Care: DRCRnet Protocol I
Research

How a Landmark Study Changed Diabetic Eye Care: DRCRnet Protocol I

Dr. Elman served as the national Study Chairman of the DRCRnet Protocol I clinical trial, a pivotal study published in the New England Journal of Medicine that transformed the standard of care for diabetic macular edema.

Mar 20, 20265 min read

Questions About Your Eye Health?

Contact Elman Retina Group to schedule a consultation with one of our retina specialists.

📞 410-686-3000